Quick Summary
Additional Context
Last month, Israeli 3D printer manufacturer Nano Dimension signed a non-binding term sheet to merge with Infinite Epigenetics, an AI-powered preventive health and diagnostics company, in a proposed deal valued at $890 million. If completed, the transaction would mark the formal end of Nano’s decade-long presence in the additive manufacturing sector, and the beginning of a new chapter in healthcare AI.
The deal is not yet final: a 30-day exclusivity period began for due diligence and negotiation of a definitive agreement, which will still require board, shareholder, and regulatory approval. That window has since closed, and, as the sections below detail, the board that negotiated the deal has since been replaced following a settlement with activist investor Murchinson Ltd.
Nano Dimension